Cite
Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
MLA
Christopher G. Schwarz, et al. “Effects of De-Facing Software Mri_reface on Utility of Imaging Biomarkers Used in Alzheimer’s Disease Research.” NeuroImage: Clinical, vol. 40, no. 103507-, Jan. 2023. EBSCOhost, https://doi.org/10.1016/j.nicl.2023.103507.
APA
Christopher G. Schwarz, Walter K. Kremers, Stephen D. Weigand, Carl M. Prakaashana, Matthew L. Senjem, Scott A. Przybelski, Val J. Lowe, Jeffrey L. Gunter, Kejal Kantarci, Prashanthi Vemuri, Jonathan Graff-Radford, Ronald C. Petersen, David S. Knopman, & Clifford R. Jack Jr. (2023). Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research. NeuroImage: Clinical, 40(103507-). https://doi.org/10.1016/j.nicl.2023.103507
Chicago
Christopher G. Schwarz, Walter K. Kremers, Stephen D. Weigand, Carl M. Prakaashana, Matthew L. Senjem, Scott A. Przybelski, Val J. Lowe, et al. 2023. “Effects of De-Facing Software Mri_reface on Utility of Imaging Biomarkers Used in Alzheimer’s Disease Research.” NeuroImage: Clinical 40 (103507-). doi:10.1016/j.nicl.2023.103507.